Febrile neutropenia in children with cancer: A retrospective Norwegian multicentre study of clinical and microbiological outcome

References

• Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99: 580–8
   PubMed Web of Science ®Google Scholar
• Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteraemia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004; 23: 61–7
   PubMed Web of Science ®Google Scholar
• Haslam DB. Managing the child with fever and neutropenia in an era of increasing microbial resistance. J Pediatr 2002; 140: 5–7
   PubMed Web of Science ®Google Scholar
• Corapcioglu F, Sarper N, Zengin E. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in paediatric cancer patients: a randomized comparison. Pediatr Hematol Oncol 2006; 23: 177–86
   PubMed Web of Science ®Google Scholar
• Fleischhack G, Hartmann C, Simon A, Wulff B, Havers W, Marklein G, et al. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 2001; 47: 841–53
   PubMed Web of Science ®Google Scholar
• Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, et al. A multicentre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility. Scand J Infect Dis 2005; 37: 455–64
   PubMed Web of Science ®Google Scholar
• Torfoss D, Hoiby EA, Tangen JM, Holte H, Bo K, Meyer P, et al. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. J Antimicrob Chemother 2007; 59: 711–7
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005; 23: 3742–51
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–51
   PubMed Web of Science ®Google Scholar
• NWGA; Norwegian Working Group for Antibiotics. http://www.unn.no/category10274.html. 18.07.07.
   Google Scholar
• Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteraemia risk in 1100 paediatric oncology patients with fever and neutropenia. Cancer 2001; 92: 909–13
   PubMed Web of Science ®Google Scholar
• Chamberlain JD, Smibert E, Skeen J, Alvaro F. Prospective audit of treatment of paediatric febrile neutropenia in Australasia. J Paediatr Child Health 2005; 41: 598–603
   PubMed Web of Science ®Google Scholar
• Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman G H. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol 2005; 23: 7958–66
   PubMed Web of Science ®Google Scholar
• Hemsworth S, Nunn AJ, Selwood K, Osborne C, Jones A, Pizer B. Once-daily netilmicin for neutropenic pyrexia in paediatric oncology. Acta Paediatr 2005; 94: 268–74
   PubMed Web of Science ®Google Scholar
• Vignoli R, Calvelo E, Cordeiro NF, Lucero R, Ingold E, Quintana A, et al. Association of broad-spectrum antibiotic use with faecal carriage of oxyiminocephalosporin-resistant enterobacteriaceae in an intensive care unit. J Hosp Infect 2006; 63: 306–15
   PubMed Web of Science ®Google Scholar
• de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973–8
   PubMed Web of Science ®Google Scholar
• Chapman RL. Prevention and treatment of candida infections in neonates. Semin Perinatol 2007; 31: 39–46
   PubMed Web of Science ®Google Scholar
• Weinberger M, Sweet S, Leibovici L, Pitlik SD, Samra Z. Correlation between candiduria and departmental antibiotic use. J Hosp Infect 2003; 53: 183–6
   PubMed Web of Science ®Google Scholar
• Bartlett JG. Narrative review: the new epidemic of Clostridium difficile associated enteric disease. Ann Intern Med 2006; 145: 758–64
   PubMed Web of Science ®Google Scholar
• Boragina M, Patel H, Reiter S, Dougherty G. Management of febrile neutropenia in paediatric oncology patients: a Canadian survey. Pediatr Blood Cancer 2007; 48: 521–6
   PubMed Web of Science ®Google Scholar
• Phillips B, Selwood K, Lane S, Skinner R, Gibson F, Chisholm JC. Variation in policies for the management of febrile neutropenia in the United Kingdom Children's Cancer Study Group centres. Arch Dis Child 2007; 92: 495–8
   PubMed Web of Science ®Google Scholar
• Phillips R, Skinner R, Chisholm JC. Treating low-risk febrile neutropenia: Jenny's story. Arch Dis Child 2007; 92: 7–8
   PubMed Web of Science ®Google Scholar
• Bodey GP, Jadeja L, Elting L. Pseudomonas bacteraemia. Retrospective analysis of 410 episodes. Arch Intern Med 1985; 145: 1621–9
   PubMed Web of Science ®Google Scholar
• NORM/NORM-VET: Usage of Antimicrobial Agents and Occurence of Antimicrobial Resistance in Norway. 2005. ISSN: 1502-2307. 2006.
   Google Scholar
• Simon A, Groger N, Wilkesmann A, Hasan C, Wiszniewsky G, Engelhart S, et al. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. Int J Antimicrob Agents 2006; 28: 417–22
   PubMed Web of Science ®Google Scholar
• Jones GR, Konsler GK, Dunaway RP, Pusek SN. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol 1996; 13: 217–29
   PubMed Web of Science ®Google Scholar
• Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 2002; 39: 77–85
   PubMedGoogle Scholar
• Santolaya ME, Alvarez AM, Becker A, Cofre J, Enriquez N, O'Ryan M, et al. Prospective, multicentre evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001; 19: 3415–21
   PubMed Web of Science ®Google Scholar